| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |